(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SMARTIMMUNE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SMARTIMMUNE

ST13

US500000098175795

Class

5, 42

Filing

98175795

Registration

7488174

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

10

Latest update

08/27/2024

Trademark type

Combined

Nice classes

5, 42

Filing date

09/12/2023

Registration date

08/27/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/27/2024

Last transaction

08/27/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

Paris, FR

Examiner

AURAND, KYLE C

Law office

N80

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized term "SMART" in navy blue and the stylized lettering "MMUNE" in navy blue with a design of five vertically stacked lavender, fuchsia, red, orange, and yellow dots therebetween which signifies the letter "I".

Holders and representatives

Holders

S. I. (pessoa física)

Representatives

PINA CAMPAGNA CARTER, DELUCA, & FARRELL, LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of pathologies linked with immunodeficiencies and oncology; stem cells for medical purposes; biological preparations for the treatment of pathologies linked with immunodeficiencies and oncology; cultures of biological tissues for medical purposes; medicines for the treatment of pathologies linked with immunodeficiencies and oncology; blood for medical purposes

Class 42

Research in the field of biologybiotechnologychemistry; medical research; pharmaceutical research; scientific research for the discovery of new drugs; provision of scientific information in the fields of medicinebiologychemistrybiotechnology; analysis and research services for medicalchemicalpharmaceutical and biological purposes; cell culture servicessorting and selection of molecules for pharmacological research purposes; development of biological testscellular tests and genetic tests

Publications

History of USPTO decisions and trademark events.

10 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/27/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/27/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/11/2024

PUBO

PUBLISHED FOR OPPOSITION

06/11/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/22/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/09/2024

DOCK

ASSIGNED TO EXAMINER

05/07/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/03/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/02/2023

NWAP

NEW APPLICATION ENTERED

09/15/2023

Continuous trademark protection

Get notified about every new filing that threatens SMARTIMMUNE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.